Le cluster H. Youdim - P. Riederer
000345 (1996) | H. Przuntek ; D. Welzel [Allemagne] ; M. Gerlach ; E. Blümner [Allemagne] ; W. Danielczyk [Autriche] ; -J. Kaiser ; H. Kraus ; H. Letzel [Allemagne] ; P. Riederer ; K. Überla [Allemagne] | Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study |
000391 (1992) | H. Przuntek [Allemagne] ; D. Welzel [Allemagne] ; E. Blümner [Allemagne] ; W. Danielczyk [Autriche] ; H. Letzel [Allemagne] ; -J. Kaiser [Allemagne] ; H. Kraus [Allemagne] ; P. Riederer [Allemagne] ; D. Schwarzmann [Allemagne] ; H. Wolf [Allemagne] ; K. Überla [Allemagne] | Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued |
000384 (1993) | H. Youdim [Israël] ; P. Riederer [Allemagne] | Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition |
000401 (1990) | K. Jellinger [Autriche] ; W. Paulus [Autriche] ; I. Grundke-Iqbal [États-Unis] ; P. Riederer [Allemagne] ; H. Youdim [Israël] | Brain iron and ferritin in Parkinson's and Alzheimer's diseases |
000408 (1988) | E. Sofic [Allemagne] ; P. Riederer [Allemagne] ; H. Heinsen [Allemagne] ; H. Beckmann [Allemagne] ; P. Reynolds [Royaume-Uni] ; G. Hebenstreit [Autriche] ; H. Youdim [Israël] | Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain |
000294 (2000) | G. Münch [Allemagne] ; H. J. Lüth [Allemagne] ; A. Wong [Allemagne] ; Th. Arendt [Allemagne] ; E. Hirsch [France] ; R. Ravid [Pays-Bas] ; P. Riederer [Allemagne] | Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation? |
000349 (1996) | M. Gerlach [Allemagne] ; P. Riederer [Allemagne] | Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man |
000378 (1993) | Youdim [Israël] ; D. Ben-Shachar [Israël] ; P. Riederer [Allemagne] | The possible role of iron in the etiopathology of parkinson's disease |
000382 (1993) | J. Kornhuber [Allemagne] ; M. Weller [Allemagne] ; P. Riederer [Allemagne] | Glutamate receptor antagonists for neuroleptic malignant syndrome and akitetic hyperthermic Parkinsonian crisis |
000403 (1989) | M. B. H. Youdim ; D. Ben-Shachar ; P. Riederer [Allemagne] | Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? |
This area was generated with Dilib version V0.6.23. |